Hydrochlorothiazide
General Information
Hydrochlorothiazide Impurities and Hydrochlorothiazide
Daicel Pharma offers excellent-quality Hydrochlorothiazide impurities, such as Hydroxy Impurity. They are vital for evaluating Hydrochlorothiazide quality, stability, and biological safety. In addition, Daicel Pharma specializes in the custom synthesis of Hydrochlorothiazide impurities and ensures worldwide delivery.
Hydrochlorothiazide [CAS: 58-93-5] is a chlorothiazide derivative. It is a diuretic and antihypertensive agent. It reduces blood pressure causing vasodilation and decreasing peripheral vascular resistance.
Hydrochlorothiazide: Use and Commercial Availability
Hydrochlorothiazide treats hypertension and peripheral edema. As a diuretic, it helps in urine excretion due to its effects on the kidneys. Further, it combines with many angiotensin-converting enzyme inhibitors. It supplements other drugs to treat edema in patients with congestive heart failure, estrogen and corticosteroid therapy, and hepatic cirrhosis. Hydrochlorothiazide is available as oral formulations under brands Esidrix, Hydrodiuril, Microzide, Oretic, etc.
Hydrochlorothiazide Structure and Mechanism of Action
The chemical name of Hydrochlorothiazide is 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide. The chemical formula for Hydrochlorothiazide is C7H8ClN3O4S2, and its molecular weight is approximately 297.74 g/mol.
Hydrochlorothiazide inhibits sodium and chloride ions reabsorption in the distal convoluted tubules of kidneys. It causes an ionic imbalance, leading to the opening of the voltage-gated channels. It decreases calcium and uric acid excretion and reduces the glomerular filtration rate.
Hydrochlorothiazide Impurities and Synthesis
During Hydrochlorothiazide synthesis1, impurities form that may affect the safety and efficacy of the drug. They form during the synthetic process, purification, or storage of Hydrochlorothiazide. And so, Hydrochlorothiazide impurities must be controlled and monitored throughout the drug development.
Daicel Pharma offers a comprehensive Certificate of Analysis (CoA) for Hydrochlorothiazide impurities, which includes Hydroxy Impurity. We provide the CoA from a cGMP-compliant analytical facility. It gives complete characterization data2 such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity. We provide additional analytical data on request. Daicel Pharma can prepare any unidentified Hydrochlorothiazide impurity or degradation product. In addition, Daicel Pharma offers highly purified, stable isotope-labeled standards of Hydrochlorothiazide. The clients of Daicel Pharma can expect a complete characterization report on delivery.
References
FAQ's
References
- Process for the manufacture of benzothiadiazines, GB880652A, Jul 31, 1958, CIBA Ltd (https://www.lens.org/lens/search/patent/list?q=GB880652A)
- VandenHeuvel, W. J. A.; Gruber, V. F.; Walker, R. W.; Wolf, F. J., GLC [gas-liquid chromatographic] analysis of hydrochlorothiazide in blood and plasma, Journal of Pharmaceutical Sciences, Volume: 64, Issue: 8, Pages: 1309-12, 1975 DOI: (10.1002/jps.2600640810)
Frequently Asked Questions
2.What is the potential Hydrochlorothiazide impurity that forms in the drug substance?
Hydrochlorothiazide-CH2- Hydrochlorothiazide isomer is the potential Hydrochlorothiazide impurity that forms in the drug substance.
3.Which analytical methods identify and analyze Hydrochlorothiazide impurities?
Ultraviolet spectroscopy, liquid chromatography/mass spectrometry, and 1H and 13C nuclear magnetic resonance (NMR) spectroscopy identify Hydrochlorothiazide impurities. RP-HPLC helps analyze Hydrochlorothiazide impurities.
4.Under which conditions do the Hydrochlorothiazide degradation products form?
Hydrochlorothiazide degradation products form under photolytic conditions.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.